Association of Risk of Suicide Attempts With Methylphenidate Treatment

Author:

Man Kenneth K. C.1,Coghill David2,Chan Esther W.3,Lau Wallis C. Y.3,Hollis Chris4,Liddle Elizabeth4,Banaschewski Tobias5,McCarthy Suzanne6,Neubert Antje7,Sayal Kapil4,Ip Patrick8,Schuemie Martijn J.9,Sturkenboom Miriam C. J. M.10,Sonuga-Barke Edmund11,Buitelaar Jan12,Carucci Sara13,Zuddas Alessandro13,Kovshoff Hanna11,Garas Peter14,Nagy Peter14,Inglis Sarah K.15,Konrad Kerstin16,Häge Alexander5,Rosenthal Eric17,Wong Ian C. K.18

Affiliation:

1. Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong2Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong3Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands4The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium

2. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium5Division of Neuroscience, School of Medicine, University of Dundee, Dundee, Scotland6Departments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia

3. Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong

4. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium7Centre for ADHD and Neuro-developmental Disorders Across the Lifespan, Institute of Mental Health, Nottingham, England8Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, England

5. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium9Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

6. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium10School of Pharmacy, University College Cork, Cork, Ireland

7. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium11Department of Paediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany

8. Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong

9. Janssen Research & Development, LLC, Titusville, New Jersey

10. Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands

11. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium13Department of Psychology, University of Southampton, Southampton, England

12. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium14Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboudumc, and Karakter Child and Adolescent Psychiatry, Nijmegen, the Netherlands

13. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium15Department of Biomedical Sciences, Section Of Neuroscience and Clinical Pharmacology, University of Cagliari, and Child and Adolescent Neuropsychiatry Unit, G. Brotzu Hospital Trust, Cagliari, Italy

14. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium16Vadaskert Child and Adolescent Psychiatric Hospital, Budapest, Hungary

15. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium5Division of Neuroscience, School of Medicine, University of Dundee, Dundee, Scotland17Tayside Clinical Trials Unit, University of Dundee, Dundee, Scotland

16. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium18Child Neuropsychology Section, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Clinics Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany

17. The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium19Evelina London Children’s Hospital, London, England

18. Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong2Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong4The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects Consortium20Research Department of Practice and Policy, University College London School of Pharmacy, London, England

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Cited by 107 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3